$3.59
00.00%
At Close: -
$3.57
-0.02-0.56%
After Hours: 4:17 PM EDT
15 minutes delayed
Comments
Loading...
Eton Pharmaceuticals
ETONNASDAQ
Eton Pharmaceuticals (NASDAQ:ETON) Stock, Analyst Ratings, Price Targets, Forecasts
Eton Pharmaceuticals Inc has a consensus price target of $9 based on the ratings of 2 analysts. The high is $10 issued by HC Wainwright & Co. on December 11, 2023. The low is $8 issued by Craig-Hallum on May 6, 2024. The 3 most-recent analyst ratings were released by Craig-Hallum, HC Wainwright & Co., and HC Wainwright & Co. on May 6, 2024, December 11, 2023, and August 11, 2023, respectively. With an average price target of $9.33 between Craig-Hallum, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 161.44% upside for Eton Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Craig-Hallum
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Eton Pharmaceuticals
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/06/2024 | Buy Now | 124.09% | Craig-Hallum | Chase Knickerbocker | → $8 | Initiates | → Buy | Get Alert |
| 12/11/2023 | Buy Now | 180.11% | HC Wainwright & Co. | Raghuram Selvaraju | → $10 | Reiterates | Buy → Buy | Get Alert |
| 08/11/2023 | Buy Now | 180.11% | HC Wainwright & Co. | Raghuram Selvaraju | $9 → $10 | Maintains | Buy | Get Alert |
| 07/03/2023 | Buy Now | 152.1% | HC Wainwright & Co. | Raghuram Selvaraju | $10 → $9 | Maintains | Buy | Get Alert |
| 03/21/2023 | Buy Now | 180.11% | HC Wainwright & Co. | Raghuram Selvaraju | → $10 | Reiterates | → Buy | Get Alert |
| 09/26/2022 | Buy Now | 180.11% | HC Wainwright & Co. | Raghuram Selvaraju | $9 → $10 | Maintains | Buy | Get Alert |
| 07/25/2022 | Buy Now | 152.1% | HC Wainwright & Co. | Raghuram Selvaraju | $11 → $9 | Maintains | Buy | Get Alert |
| 03/22/2022 | Buy Now | 208.12% | HC Wainwright & Co. | Raghuram Selvaraju | $14 → $11 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Eton Pharmaceuticals (ETON) stock?
The latest price target for Eton Pharmaceuticals (NASDAQ:ETON) was reported by Craig-Hallum on May 6, 2024. The analyst firm set a price target for $8.00 expecting ETON to rise to within 12 months (a possible 124.09% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Eton Pharmaceuticals (ETON)?
The latest analyst rating for Eton Pharmaceuticals (NASDAQ:ETON) was provided by Craig-Hallum, and Eton Pharmaceuticals initiated their buy rating.
When was the last upgrade for Eton Pharmaceuticals (ETON)?
There is no last upgrade for Eton Pharmaceuticals
When was the last downgrade for Eton Pharmaceuticals (ETON)?
There is no last downgrade for Eton Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Eton Pharmaceuticals (ETON)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Eton Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Eton Pharmaceuticals was filed on May 6, 2024 so you should expect the next rating to be made available sometime around May 6, 2025.
Is the Analyst Rating Eton Pharmaceuticals (ETON) correct?
While ratings are subjective and will change, the latest Eton Pharmaceuticals (ETON) rating was a initiated with a price target of $0.00 to $8.00. The current price Eton Pharmaceuticals (ETON) is trading at is $3.57, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.